CoChat

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

Drevets, W · 2002 · European Neuropsychopharmacology

The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.

Abstract

Neurophysiological studies of major depression performed using PET imaging have shown abnormalities of regional cerebral blood flow (CBF) and glucose metabolism in multiple prefrontal cortical and limbic structures that have been more generally implicated in emotional processing. The current study investigated the effects of antidepressant drug treatment in these regions using PET measures of glucose metabolism. Subjects with primary MDD (n=27) were imaged while unmedicated and depressed, and, of these, 20 were rescanned following chronic antidepressant drug treatment. Regional metabolism was compared between unmedicated depressives and controls and between the pre- and post-treatment conditions in regions-of-interest (ROI) where metabolism or flow had previously been shown to be abnormal in unmedicated depressives. At baseline, the mean metabolism was increased in the left and right lateral orbital cortex/ventrolateral prefrontal cortex (PFC), left amygdala, and posterior cingulate cortex, and decreased in the subgenual ACC and dorsal medial/dorsal anterolateral PFC in the unmedicated depressives relative to controls, consistent with the results of previous studies. Following treatment, metabolism significantly decreased in the left amygdala and left subgenual ACC, and corresponding changes in the orbital and posterior cingulate cortices approached significance. The metabolic reduction in the amygdala and right subgenual ACC appeared largely limited to those subjects who both responded to treatment and remained well at 6 months follow-up, in whom the reduction in amygdala metabolism tightly correlated with the reduction in HDRS scores. The magnitude of the treatment-associated, metabolic change in the amygdala also correlated positively with the change in the stressed plasma cortisol levels measured during scanning. These data converge with those from other PET studies to indicate that primary MDD is associated with abnormal metabolism in limbic and paralimbic structures of the mesiotemporal and prefrontal cortices. Chronic antidepressant drug treatment reduces metabolism in the amygdala and ventral ACC in subjects showing a persistent, positive treatment response. In contrast, the persistence of the abnormal metabolic deficits in the dorsomedial/dorsal anterolateral PFC in MDD during treatment may conceivably relate to the histopathological changes reported in these regions in post mortem studies of MDD.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0924-977x(02)00102-5

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 129 references

Cited by

See all 581

Metadata

Authors
Drevets, W.
Affiliations
National Institutes of Health (US)
Corresponding author
Drevets, W
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
2002-12
Volume
12
Issue
6
Pages
527-544
ISSN
0924-977X (ISSN-L)
OpenAlex
W2027721376
Cited by
581
References
129
Citations by year
2026: 6 · 2025: 7 · 2024: 16 · 2023: 17 · 2022: 14 · 2021: 19 · 2020: 17 · 2019: 22 · 2018: 21 · 2017: 20 · 2016: 26 · 2015: 23 · 2014: 31 · 2013: 36 · 2012: 40
FWCI
9.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r29mh051137-04, 1k20mh000928-01)
  • National Institute of Mental Health (MH-00928, MH51137)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
major depressive disorder, antidepressant response, regional cerebral glucose metabolism, amygdala, subgenual anterior cingulate cortex, ventrolateral prefrontal cortex, posterior cingulate cortex, orbital cortex, plasma cortisol, treatment response prediction
MeSH terms
Adolescent, Adult, Antidepressive Agents, Brain, Brain Mapping, Depressive Disorder, Major, Major Depressive Disorder, Female, Glucose, Humans, Male, Middle Aged, Oxygen Consumption, Psychiatric Status Rating Scales, Tomography, Emission-Computed, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. https://app.cochat.ai/papers/10.1016/s0924-977x(02)00102-5
The paper
Drevets, W. (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology. https://doi.org/10.1016/s0924-977x(02)00102-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.